Potential for myeloablation with yttrium-90-labeled HuM195 (anti-CD33): A phase I trial in advanced myeloid leukemias Meeting Abstract
| Authors: | Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Ma, D.; Sgouros, G.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A. |
| Abstract Title: | Potential for myeloablation with yttrium-90-labeled HuM195 (anti-CD33): A phase I trial in advanced myeloid leukemias |
| Meeting Title: | 40th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 92 |
| Issue: | 10 Suppl. 1 Pt. 1 |
| Meeting Dates: | 1998 Dec 4-8 |
| Meeting Location: | Miami Beach, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 1998-11-15 |
| Start Page: | 613a |
| Language: | English |
| ACCESSION: | WOS:000077121302515 |
| PROVIDER: | wos |
| PUBMED: | 9835841 |
| Notes: | Meeting Abstract: 2528 -- Source: Wos |
Citation Impact
